Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

4319 - Single-cell combined mutation and gene expression studies of circulating tumor-associated cells in non-small cell lung cancer

Date

11 Sep 2017

Session

Poster display session

Topics

Cancers in Adolescents and Young Adults (AYA);  Translational Research;  Thoracic Malignancies

Presenters

Jamie Mong

Citation

Annals of Oncology (2017) 28 (suppl_5): v22-v42. 10.1093/annonc/mdx363

Authors

J. Mong1, J. Shi1, T.M. Chin2, S. Wong3, A. Tee4, D. Chan5, K. Wong6, S. Yeap7, L. Ngo8, Y. Tan9, M. Hu1, J. Ying1, M. Tan1

Author affiliations

  • 1 Biodevices And Diagnostics, Insitute of Bioengineering and Nanotechnology (IBN), 138669 - Singapore/SG
  • 2 Department Of Haematology-oncology, National University Hospital, 119074 - Singapore/SG
  • 3 The Cancer Centre, The Cancer Centre, 238859 - Singapore/SG
  • 4 Department Of Respiratory & Critical Care Medicine, Changi General Hospital, 529889 - Singapore/SG
  • 5 Singapore Oncology Consultants, Singapore Oncology Consultants, 228510 - Singapore/SG
  • 6 Soc @ Gleneagles, SOC @ Gleneagles, Singapore/SG
  • 7 Novena Cancer Center, Novena Cancer Center-Mount Elizabeth Specialist Centre, 329563 - Singapore/SG
  • 8 Cancer Centre, Raffles Medical Group, 188770 - Singapore/SG
  • 9 Soc Clinic, Farrer Park Hospital & Medical Centre, 217562 - Singapore/SG
More

Resources

Abstract 4319

Background

Circulating tumor cells (CTC) in the bloodstream not only provide us a sampling of the tumor population but are also keys to the metastatic process. Most CTC enrichment devices are coupled to downstream marker analysis by immunocytochemistry that define CTC as CD45-negative and epithelial marker (e.g. EPCAM)-positive cells. Our group recently reported a new class of tumor-derived cells in circulation, the circulating tumor-endothelial cluster, in colorectal cancer. This demonstrated that tumor-associated cells in circulation hitherto considered malignant may instead and unexpectedly provide key insights to the tumor microenvironment. To effectively classify the circulating cell milieu in lung cancer, we used a single-cell technique RNA and mutation analysis (scrm-PCR) we have described previously to characterize DNA and RNA from the same cell.

Methods

We enriched for CTC from whole blood of non-small cell lung cancer (NSCLC) patients using silicon microsieves with uniformly spaced 8 to 10uM circular pores. We manually selected captured single cells or cell clusters for characterization. 50 single cell or cell clusters from 5 NSCLC patients and 2 healthy subjects were probed for a curated panel of 27 RNA markers and hotspot DNA mutations in EGFR, TP53 and KRAS by scrm-PCR.

Results

Classic epithelial markers such as EPCAM are largely unexpressed in CD45-negative cells in NSCLC. DNA mutations were undetected in all isolated cells except for 1 cell. CD45-negative cell clusters in NSCLC exhibit a different phenotypic profile as compared to our report of tumor-endothelial in colorectal cancer, failing to express classic endothelial markers such as VWF, MCAM and CDH5. We identified important morphological features correlating with biological phenotypic classification of these cells, allowing us to establish a map of the circulating cell milieu of NSCLC.

Conclusions

This is the first systematic same-cell combined mutation and expression analysis of circulating cells in NSCLC patients. With this novel approach, we report the presence of predominantly tumor-associated cells rather than malignant cells in circulation, and highlight the potential of these cells as biomarkers of NSCLC and its tumor microenvironment.

Clinical trial identification

Legal entity responsible for the study

Institute of Bioengineering and Nanotechnology

Funding

Agency for Science, Technology and Research (A*STAR)

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.